IMPLANT COMPRISING A CONTROLLED-RELEASE FORMULATION COMPRISING OCTREOTIDE WITH HYDROGEL (VARIANTS) AND METHOD FOR TREATING ACROMEGALIA

摘要

A formulation of octreotide or pharmaceutically acceptable salts thereof, which provides controlled release of a therapeutically effective amount of octreotide for a period of at least about two months. Methods of treating acromegaly, decreasing growth hormone, decreasing IGF-1, and treating conditions associated with carcinoid tumors and VIPomas by administering a controlled release formulation of octreotide are provided herein.